Analysis

Shkreli's Brazen Defiance May Lead To Harsher Sentence

Law360, New York (August 7, 2017, 9:06 PM EDT) -- Public statements from former Turing Pharmaceuticals and Retrophin CEO Martin Shkreli deriding the prosecution’s securities fraud case against him may come back to bite him at sentencing, legal experts said Monday.

Shkreli has not shied from the spotlight since his conviction Friday on two counts of securities fraud and another conspiracy charge. He has accused prosecutors of leading a “witch hunt,” and told his followers on social media that the government had “concocted a fantasy world of eight criminal counts connecting nonexistent dots into an elaborate...
To view the full article, register now.